Q3 2024 Revenue Guidance -- Management expects RMB1.9 billion to RMB1.92 billion, implying growth of 18.2%-19.5% year over ...

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Good morning, everyone, and thanks for joining us for the Adler Group 2025 Results Call. Speakers today, as usual, are our CEO, Dr. Karl Reinitzhuber; and our CFO, Thorsten Arsan. Both will guide you ...

FactSet Research Systems Inc. (NYSE:FDS) Q2 2026 Earnings Call Transcript March 31, 2026 FactSet Research Systems Inc. misses on earnings expectations. Reported EPS is $3.6 EPS, expectations were ...

Welcome to the earnings call of Aumann AG regarding the full year figures for 2025. The company's CEO, Sebastian Roll; and CFO, Jan-Henrik Pollitt, will guide you through the presentation and the ...

Worthington Industries, Inc. (NYSE:WOR) Q3 2026 Earnings Call Transcript March 25, 2026 Operator: Good morning, and welcome to the Worthington Enterprises Third Quarter Fiscal 2026 Earnings Conference ...

First, this was another outstanding quarter for AAR. Total sales increase included 14% organic adjusted sales growth led by ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, Inc.’s transition from a development-stage platform company into a commercial ...

Noodles & Company (NASDAQ:NDLS) Q4 2025 Earnings Call Transcript March 25, 2026 Noodles & Company misses on earnings ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

Adjusted EBITDA -- $42 million, up 2.6%, with adjusted EBITDA margin at 11.8% for the year. Syndicated Audience Revenue -- ...

The following is the transcript of the interview with Iran policy analyst Karim Sadjadpour and former CENTCOM commander and ...